Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 13 de 13
Filtre
Ajouter des filtres








Gamme d'année
1.
Asian Pac J Allergy Immunol ; 2000 Jun; 18(2): 85-92
Article Dans Anglais | IMSEAR | ID: sea-37195

Résumé

Stem cell transplantation (SCT) has become the therapy of choice for many hematologic and immunologic disorders. At present, only 25% of patients have suitable HLA-identical donors. In an attempt to increase the donor pool for SCT in Thailand and Southeast Asia, we developed a program whereby parents and mismatched siblings can be used as donors. In this preliminary study, after granulocyte-colony-stimulating factor (G-CSF) was given to adult donors, peripheral blood stem cells (PBSC) were collected and CD34+ cells purified using a CliniMACS immunomagnetic device (Miltenyi Biotec, Germany). In seven experiments, purified CD34+ cells could be obtained from G-CSF-stimulated PBSC in large numbers (1.71 +/- 0.19 x 10(8)), with high purity (93 +/- 2.4%) and excellent recovery (64.28% - 85.62%). Immune reactive T and NK cells were adequately depleted to less than 0.2%. The purification procedure can be completed within 3 hours. In conclusion, a clinical stem cell purification program using this novel device is now established in Thailand and for the first time in Southeast Asia. This should allow further development of advanced SCT therapy including haploidentical and mismatched CD34+ SCT for patients' lacking HLA-identical donors in this region.


Sujets)
Adulte , Antigènes CD34/analyse , Hémogramme , Donneurs de sang , Cytométrie en flux , Maladie du greffon contre l'hôte/prévention et contrôle , Facteur de stimulation des colonies de granulocytes/administration et posologie , Mobilisation de cellules souches hématopoïétiques , Transplantation de cellules souches hématopoïétiques/méthodes , Cellules souches hématopoïétiques/immunologie , Humains , Séparation immunomagnétique , Leucaphérèse , Déplétion lymphocytaire , Famille nucléaire , Parents , Thaïlande
2.
Southeast Asian J Trop Med Public Health ; 1995 ; 26 Suppl 1(): 291-5
Article Dans Anglais | IMSEAR | ID: sea-31766

Résumé

The hematopoietic committed progenitor cells (BFU-E and CFU-GM) in blood and bone marrow were studied in thalassemic patients before and after bone marrow transplantation. Eighteen transplants were performed in 17 patients with thalassemia. Five were homozygous beta-thalassemia and 12 were beta-thalassemia/hemoglobin E disease. The age ranged from 1.2-14 years (median = 3.4 years). The conditioning regimen comprised busulfan 3.5-4 mg/kg/day for 4 days and cyclophosphamide 50 mg/kg/day for 4 days. Cyclosporin in combination with methotrexate were administered post transplant for GVHD prophylaxis. Before transplantation, BFU-E and CFU-GM in the blood of the patients were significantly higher compared with normal (p < 0.05) but were normal in the bone marrow. Only the CFU-GM in the bone marrow of the successful cases after transplantation recovered to the normal level at the first month through the 12th month whereas the BFU-E were low. Both CFU-GM and BFU-E in the blood were lower than normal after follow up to the 12th month. Inspite of the low number of progenitor cells, there was hematological recovery in the blood of the patients. It may be due to the capacity of the hematopoiesis react to stress which could be amplified the differentiation compartment or the shortened-transit time through the stem cell compartment.


Sujets)
Moelle osseuse/anatomopathologie , Transplantation de moelle osseuse , Busulfan/usage thérapeutique , Cellules cultivées , Enfant , Enfant d'âge préscolaire , Test clonogénique , Cyclophosphamide/usage thérapeutique , Ciclosporine/usage thérapeutique , Femelle , Maladie du greffon contre l'hôte/prévention et contrôle , Cellules souches hématopoïétiques/anatomopathologie , Hémoglobine E , Hémoglobinurie/anatomopathologie , Homozygote , Humains , Immunosuppresseurs/usage thérapeutique , Nourrisson , Mâle , Méthotrexate/usage thérapeutique , Valeurs de référence , bêta-Thalassémie/anatomopathologie
3.
Article Dans Anglais | IMSEAR | ID: sea-38803

Résumé

Cytochemical studies including peroxidase, sudan black B and esterases were used for staining peripheral blood and bone marrow smears from 42 patients with acute promyelocytic leukemia. The most sensitive methods were sudan black B (mean 98%, range 81-100%) and peroxidase (mean 92% range 70-100%). Naphthol AS-D chloroacetate esterase activity was less sensitive and was positive in only 49.4 per cent (range 2-100%). All of the population of leukemic cells contained less than 3 per cent of alpha-naphthyl acetate esterase staining. For stability tests of the storage specimens compared to fresh stains, there was no difference in naphthol AS-D chloroacetate esterase (mean 45% vs 49% P greater than 0.7) and sudan black B (mean 74% vs 98% P greater than 0.3), but the enzyme activity was significantly decreased in peroxidase staining (mean 42% vs 92% P greater than 0.05). When the patients were divided into 2 groups according to the degree of AS-D chloroacetate esterase activity, those with lower activity had a higher number of white blood cells, promyelocytes and shorter survival compared to those with higher activity. Therefore, naphthol AS-D chloroacetate esterase may be useful as a prognostic index.


Sujets)
Adolescent , Adulte , Sujet âgé , Composés azoïques/diagnostic , Myélogramme , Esterases/diagnostic , Études d'évaluation comme sujet , Femelle , Humains , Leucémie aiguë promyélocytaire/sang , Mâle , Adulte d'âge moyen , Myeloperoxidase/diagnostic , Sensibilité et spécificité
4.
Article Dans Anglais | IMSEAR | ID: sea-39617

Résumé

Massive chemotherapy and autologous bone marrow transplantation (ABMT) have been successfully used for the treatment of Burkitt's lymphoma. We report our first success with such treatment in two children with Burkitt's lymphoma in Thailand. Both patients had massive abdominal tumors with ascites and minimal bone marrow metastasis at the first presentation. They received induction chemotherapy and intensive treatment including central nervous system prophylaxis with cranial irradiation and intrathecal methotrexate until being in complete remission before starting massive chemotherapy, comprising the combination of BCNU, cytosine arabinoside, cyclophosphamide and 6-thioguanine followed by ABMT. Both patients recovered completely following intensive supportive treatments post ABMT and are still good health without evidence of the disease for 18 and 8 months after transplantation respectively. The role of massive chemotherapy and ABMT for the treatment of non-Hodgkin's lymphoma especially Burkitt's lymphoma was discussed.


Sujets)
Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Transplantation de moelle osseuse , Lymphome de Burkitt/épidémiologie , Carmustine/administration et posologie , Enfant , Association thérapeutique , Cyclophosphamide/administration et posologie , Cytarabine/administration et posologie , Femelle , Humains , Mâle , Thaïlande/épidémiologie , Tioguanine/administration et posologie
5.
Article Dans Anglais | IMSEAR | ID: sea-40983

Résumé

Hematopoietic progenitor cells were studied in 11 patients with aplastic anemia who had hematologic recovery after androgen therapy. The mean numbers of colonies derived from erythroid and granulocyte-macrophage progenitor cells (BFU-E and CFU-GM) were markedly decreased compared to normal controls. Cell-mediated suppression of colony growth as detected by coculture studies was observed in 5 patients; 4 patients for CFU-GM and one for both CFU-GM and BFU-E. It is thus concluded that the pool of hematopoietic stem cells in patients after hematologic recovery is still not fully reconstituted. In addition, this impaired reconstitution appears due in some cases to cell mediated suppression of progenitor colony growth.


Sujets)
Adolescent , Adulte , Sujet âgé , Androgènes/usage thérapeutique , Anémie aplasique/sang , Moelle osseuse/anatomopathologie , Études d'évaluation comme sujet , Femelle , Cellules souches hématopoïétiques/anatomopathologie , Humains , Mâle , Adulte d'âge moyen
7.
Asian Pac J Allergy Immunol ; 1988 Jun; 6(1): 33-7
Article Dans Anglais | IMSEAR | ID: sea-37253

Résumé

The pathogenesis of aplastic anemia in Thailand was studied by using in vitro progenitor cells culture. In 37 patients who had active disease, the numbers of colonies derived from erythroid and granulocyte-macrophage progenitor cells (BFU-E and CFU-GM) were markedly decreased both in the blood and bone marrow as compared to normal controls. Co-culture of patients' cells with normal blood cells was performed in order to verify an immunologically mediated mechanism. In 8 of 26 patients, there were very low numbers of colonies both BFU-E and CFU-GM in the blood and bone marrow with significant suppression of colony formation in co-culture. Suppressor cells may have caused the aplasia in these patients. The rest had low colony formation and no suppression in co-culture. These patients may have absent or defective stem cells. None had normal colony formation. Therefore, aplastic anemia in Thailand may result mostly from defects involving the stem cells. Only some patients had cell mediated suppression of hematopoiesis as detected by co-culture.


Sujets)
Adolescent , Adulte , Anémie aplasique/étiologie , Cellules sanguines/immunologie , Moelle osseuse/immunologie , Numération cellulaire , Enfant , Test clonogénique , Femelle , Cellules souches hématopoïétiques/immunologie , Humains , Mâle , Adulte d'âge moyen , Lymphocytes T régulateurs/immunologie , Thaïlande
9.
Asian Pac J Allergy Immunol ; 1986 Jun; 4(1): 29-32
Article Dans Anglais | IMSEAR | ID: sea-36628

Résumé

Twenty patients with aplastic anaemia were treated with a short term bolus of methylprednisolone. Seven patients were refractory to anabolic steroids and were observed in very long follow-up periods of 14-104 months. Thirteen patients had never been treated. The latter group also received anabolic steroids. Five out of 20 patients responded to the treatment while the remaining patients did not or died. Responders among patients refractory to anabolic steroids had shorter duration of disease compared to non-responders. No recurrence of aplasia was observed in all responders.


Sujets)
Adolescent , Adulte , Sujet âgé , Anabolisants/usage thérapeutique , Anémie aplasique/traitement médicamenteux , Maladie chronique , Essais cliniques comme sujet , Résistance aux substances , Femelle , Humains , Mâle , Méthylprednisolone/administration et posologie , Adulte d'âge moyen
SÉLECTION CITATIONS
Détails de la recherche